Rapado-González, Ó.; Martínez-Reglero, C.; Salgado-Barreira, Á.; Santos, M.A.; López-López, R.; Díaz-Lagares, Á.; Suárez-Cunqueiro, M.M.
Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part II: A Cancer Risk Meta-Analysis. J. Pers. Med. 2021, 11, 606.
https://doi.org/10.3390/jpm11070606
AMA Style
Rapado-González Ó, Martínez-Reglero C, Salgado-Barreira Á, Santos MA, López-López R, Díaz-Lagares Á, Suárez-Cunqueiro MM.
Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part II: A Cancer Risk Meta-Analysis. Journal of Personalized Medicine. 2021; 11(7):606.
https://doi.org/10.3390/jpm11070606
Chicago/Turabian Style
Rapado-González, Óscar, Cristina Martínez-Reglero, Ángel Salgado-Barreira, María Arminda Santos, Rafael López-López, Ángel Díaz-Lagares, and María Mercedes Suárez-Cunqueiro.
2021. "Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part II: A Cancer Risk Meta-Analysis" Journal of Personalized Medicine 11, no. 7: 606.
https://doi.org/10.3390/jpm11070606
APA Style
Rapado-González, Ó., Martínez-Reglero, C., Salgado-Barreira, Á., Santos, M. A., López-López, R., Díaz-Lagares, Á., & Suárez-Cunqueiro, M. M.
(2021). Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part II: A Cancer Risk Meta-Analysis. Journal of Personalized Medicine, 11(7), 606.
https://doi.org/10.3390/jpm11070606